A Selective Transforming Growth Factor-β Ligand Trap Attenuates Pulmonary Hypertension

Abstract

Our findings are consistent with a pathogenetic role of TGF-β1/3, demonstrating the efficacy and tolerability of selective TGF-β ligand blockade for improving hemodynamics, remodeling, and survival in multiple experimental PH models.